TOP STORIES
respiratory
ILD

Promising results for treprostinil in pulmonary hypertension associated with ILD


Inhaled treprostinil shows some promise as a treatment for pulmonary hypertension associated with ILD, according to US research. The study randomised 326 patients to treprostinil (0.6 mg per ml) or placebo delivered by a nebuliser four times daily for 16 weeks....

Inhaled treprostinil shows some promise as a treatment for pulmonary hypertension associated with ILD, according to US research. The study randomised...

Read more